TickerFacts.

Black Diamond Therapeutics, Inc. (BDTX): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$62.30M
Year ended 2024-12-31
2018-12-31: -$8.53M2019-12-31: -$24.70M2020-12-31: -$52.29M2021-12-31: -$102.86M2022-12-31: -$85.27M2023-12-31: -$66.75M2024-12-31: -$62.30M-$62.30M
2018-12-31 Free Cash Flow (USD) 2024-12-31
Period endedFree Cash FlowChange YoYSource filing
2024-12-31-$62.30Mn/m2026-03-16, From 2024-01-01
2023-12-31-$66.75Mn/m2025-03-06, From 2023-01-01
2022-12-31-$85.27Mn/m2024-03-12, From 2022-01-01
2021-12-31-$102.86Mn/m2023-03-09, From 2021-01-01
2020-12-31-$52.29Mn/m2022-03-17, From 2020-01-01
2019-12-31-$24.70Mn/m2021-03-25, From 2019-01-01
2018-12-31-$8.53Mn/a2020-03-24, From 2018-01-01